International Isotopes Inc. (INIS)
|Net Income (ttm)||2.02M|
|Trading Day||June 18|
|Day's Range||0.1325 - 0.1470|
|52-Week Range||0.0430 - 0.2095|
IDAHO FALLS, Idaho, May 18, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2021. Revenue...
IDAHO FALLS, Idaho, March 31, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2020. Total revenues ...
IDAHO FALLS, Idaho, Jan. 26, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce the following developments. International Isotopes recently signed a di...
International Isotopes Inc. Comments On The Unusual Trading Volume And Share Price Volatility In Its Common Stock
IDAHO FALLS, Idaho, Jan. 21, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stock, is prov...
International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Radiological Services. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient posit... [Read more...]
Drug Manufacturers-Specialty & Generic
|IPO Date |
Aug 14, 1997
|Stock Exchange |
|Ticker Symbol |
The average 12-month stock price forecast for INIS is 0.12, which is a decrease of -13.04% from the latest price.